Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
Cochrane Reviews,  Clinical Article

Walters JAE et al. – The authors based assessment of the efficacy of short compared to longer duration systemic corticosteroid therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD) in this review on four of the seven included studies for which data were available. The finding in this review that there is no significant increase in treatment failure with shorter systemic corticosteroid treatment for seven days or less for acute exacerbations of COPD, does not give conclusive evidence to recommend change in clinical practice due to a wide confidence interval around the estimate of effect.

Methods
  • The authors searched the Cochrane Airways Group Register of Trials (to April 2011) Cochrane Central Register of Controlled Trials (to April 2011), MEDLINE (from 1950 to October 2010), EMBASE (from 1980 to October 2010) and the reference lists of articles.
  • Randomised controlled trials comparing different durations of SC (seven days or fewer or more than seven days).
  • Other interventions, e.g. bronchodilators and antibiotics, were standardised; studies in other lung diseases were excluded, unless data on participants with COPD were available.
  • Two review authors independently extracted data that were pooled them using Review Manager 5.
  • The authors sought missing data from authors of studies published as abstracts only.

Results
  • The authors identified seven studies including 288 participants; two studies were fully published and five were published as abstracts.
  • The authors obtained data for two studies published as abstracts from authors; these two abstracts and the two full papers contributed to meta–analysis.
  • No study specified COPD diagnostic criteria and only one specified exacerbation criteria.
  • Short course treatment varied between three and seven days and longer duration 10 to 15 days, at equivalent daily doses of corticosteroids; five studies used oral prednisolone (dose 30 mg, four studies, one tapered dose) and two studies used intravenous corticosteroid treatment.
  • Mean ages of participants ranged from 64 to 73 years.
  • The authors assessed the risk of allocation and blinding bias as low for these studies.
  • Primary outcomes: risk of treatment failure did not differ significantly by treatment duration, but the confidence interval (CI) was too wide to conclude equivalence (odds ratio (OR) 0.94, 95% CI 0.38 to 2.36) (three studies, n = 158).
  • Forced expiratory volume in 1 second (FEV1) did not differ significantly when measured up to seven days (mean difference (MD) 0.07 L, 95% CI 0.19 to 0.05) or after seven days (MD 0.02 L, 95% CI 0.10 to 0.06) (four studies, n = 197).
  • The likelihood of an adverse event (four studies, n = 102) did not differ significantly by treatment duration, but again the CI was wide (OR 0.58, 95% CI 0.14 to 2.40).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

3 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

4 Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years: National Health Interview Survey data 2004 to 2011 Journal of Occupational and Environmental Medicine, October 17, 2014    Clinical Article

5 Efficacy of mycophenolate mofetil in sarcoidosis Respiratory Medicine, October 29, 2014    Review Article

6 The effects of high intensity exercise during pulmonary rehabilitation on ventilatory parameters in people with moderate to severe stable COPD: A systematic review Full Text International Journal of COPD, October 14, 2014    Free full text    Evidence Based Medicine    Clinical Article

7 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

8 Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD Full Text International Journal of COPD, October 24, 2014    Free full text    Clinical Article

9 Predictors of physical inactivity in elderly patients with chronic obstructive pulmonary disease Full Text International Journal of Gerontology, September 25, 2014    Free full text    Clinical Article

10 Prophylactic antibiotic therapy after inhalation injury Burns, October 10, 2014    Clinical Article

11 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

12 Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis Chest, September 9, 2014    Clinical Article

13 The clinical features of sarcoidosis: a comprehensive review Clinical Reviews in Allergy and Immunology, October 10, 2014    Clinical Article

14 Comparison of US emergency department acute asthma care quality: 1997-2001 and 2001-2012 The Journal of Allergy and Clinical Immunology, October 7, 2014    Clinical Article

15 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

16 Benefits of an oxygen reservoir cannula versus a conventional nasal cannula during exercise in hypoxemic COPD patients: A crossover trial Respiration, October 21, 2014    Clinical Article

17 Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: A post-hoc analysis of the 4-year UPLIFT trial Full Text BMC Pulmonary Medicine, October 22, 2014    Free full text    Clinical Article

18 Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease Respiratory Medicine, October 3, 2014    Clinical Article

19 The use of N-acetylcysteine in respiratory diseases Current Respiratory Medicine Reviews, July 17, 2014    Review Article

20 Cold spells and the risk of hospitalization for asthma: New York, USA 1991–2006 Lung, October 15, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore